NeuPath Health Inc.

TSXV:NPTH Stock Report

Market Cap: CA$9.0m

NeuPath Health Management

Management criteria checks 2/4

NeuPath Health's CEO is Joe Walewicz, appointed in Sep 2022, has a tenure of 2.17 years. total yearly compensation is CA$576.57K, comprised of 56.4% salary and 43.6% bonuses, including company stock and options. directly owns 0.67% of the company’s shares, worth CA$60.11K. The average tenure of the management team and the board of directors is 3.3 years and 4.4 years respectively.

Key information

Joe Walewicz

Chief executive officer

CA$576.6k

Total compensation

CEO salary percentage56.4%
CEO tenure2.2yrs
CEO ownership0.7%
Management average tenure3.3yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

Aug 18
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel

These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

Jun 16
These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively

The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Apr 23
The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet

Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Mar 01
Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?

Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Dec 20
Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%

Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

Aug 19
Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues

CEO Compensation Analysis

How has Joe Walewicz's remuneration changed compared to NeuPath Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$852k

Jun 30 2024n/an/a

-CA$74k

Mar 31 2024n/an/a

-CA$293k

Dec 31 2023CA$577kCA$325k

-CA$107k

Sep 30 2023n/an/a

-CA$2m

Jun 30 2023n/an/a

-CA$3m

Mar 31 2023n/an/a

-CA$3m

Dec 31 2022CA$395kCA$117k

-CA$4m

Sep 30 2022n/an/a

-CA$3m

Jun 30 2022n/an/a

-CA$3m

Mar 31 2022n/an/a

-CA$3m

Dec 31 2021CA$38kn/a

-CA$3m

Sep 30 2021n/an/a

-CA$3m

Jun 30 2021n/an/a

-CA$3m

Mar 31 2021n/an/a

-CA$5m

Dec 31 2020CA$32kn/a

-CA$5m

Compensation vs Market: Joe's total compensation ($USD412.50K) is above average for companies of similar size in the Canadian market ($USD169.13K).

Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.

CEO

Joe Walewicz (55 yo)

2.2yrs

Tenure

CA$576,570

Compensation

Mr. Joseph Andrew Walewicz, also known as Joe, MBA, CFA, CLP served as Interim CEO at NeuPath Health Inc. since September 30, 2022 and has been its Director since June 25, 2020. He serves as Chief Executiv...

Leadership Team

NamePositionTenureCompensationOwnership
Joseph Walewicz
CEO & Director2.2yrsCA$576.57k0.67%
CA$ 60.1k
Jeff Zygouras
CFO & Corporate Secretary3.3yrsCA$488.18k0.079%
CA$ 7.1k
Bjorn Thies
Vice President of People & Culture3.6yrsno datano data

3.3yrs

Average Tenure

Experienced Management: NPTH's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Joseph Walewicz
CEO & Director4.4yrsCA$576.57k0.67%
CA$ 60.1k
Daniel Chicoine
Independent Chair4.4yrsCA$113.12k0.17%
CA$ 15.7k
Daniel Legault
Independent Director5.6yrsCA$58.12k0.22%
CA$ 19.7k
Jolyon Burton
Independent Director4.4yrsno datano data
Sasha Cucuz
Independent Director4.4yrsCA$64.12k0.094%
CA$ 8.5k

4.4yrs

Average Tenure

55yo

Average Age

Experienced Board: NPTH's board of directors are considered experienced (4.4 years average tenure).